e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Miscellaneous including cancer epidemiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased mortality rate associated with prescribed opioid medications: is there a link with sleep disordered breathing?
C. A. Porucznik, R. J. Farney, J. M. Walker, R. T. Rolfs, T. Grey (Salt Lake City, United States Of America)
Source:
Annual Congress 2005 - Miscellaneous including cancer epidemiology
Session:
Miscellaneous including cancer epidemiology
Session type:
Thematic Poster Session
Number:
3809
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. A. Porucznik, R. J. Farney, J. M. Walker, R. T. Rolfs, T. Grey (Salt Lake City, United States Of America). Increased mortality rate associated with prescribed opioid medications: is there a link with sleep disordered breathing?. Eur Respir J 2005; 26: Suppl. 49, 3809
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Refractory sleep disordered breathing associated with chronic opioid therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 88s
Year: 2001
Does chronic opioid therapy alter the pattern of sleep apnea?
Source: Eur Respir J 2004; 24: Suppl. 48, 446s
Year: 2004
Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients
Source: ERJ Open Res, 6 (3) 00093-2020; 10.1183/23120541.00093-2020
Year: 2020
The effect of sleep-disordered breathing (SDB) on adverse consequences associated with opioid use: A population study
Source: Virtual Congress 2020 – Determinants of chronic respiratory diseases
Year: 2020
Do beta-blockers reduce sympathetic activity in patients with mild sleep breathing disorder without CPAP therapy?
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020
Impact of bi-Level ventilation on sleep disordered breathing in patients using chronic opioids
Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Year: 2010
Daytime sleepiness in patients on intrathecal chronic opioid (IT) therapy is not related to sleep disordered breathing (SDB)
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011
Cardiovascular consequences of sleep disordered breathing: the role of CPAP treatment
Source: Eur Respir Monogr 2020; 88: 118-142
Year: 2020
Adaptive servo-ventilation (ASV) therapy for sleep disordered breathing (SDB) associated with opioid medications
Source: Annual Congress 2007 - Sleep apnoea and adaptive servo–ventilation
Year: 2007
Is there an association between self-reported nasal congestion and symptoms of sleep disordered breathing in hospital employees?
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008
Is cardiovascular co-morbidity increasing success rate of smoking cessation at respiratory disorders inpatients?
Source: Annual Congress 2007 - Smoking cessation
Year: 2007
Residual sleep apnea on CPAP: prevalence, predictors and patterns
Source: Annual Congress 2008 - Outcome of adaptive servo ventilation in sleep apnoea
Year: 2008
Cardiovascular risk and sleep disordered breathing: what’s up?
Source: International Congress 2016 – Obesity and respiratory diseases
Year: 2016
Mortality in sleep apnoea syndrome: a review of the evidence
Source: Eur Respir Rev 2007; 16: 203-210
Year: 2007
The prevalence of sleep disordered breathing in subjects with moderate, optimally managed heart failure
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008
CPAP treatment for sleep apnea syndrome: compliance increases with very long term use
Source: Eur Respir J 2005; 26: Suppl. 49, 723s
Year: 2005
Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment
Source: Eur Respir J 2012; 39: 906-912
Year: 2012
Does the provision of home nasal ventilation reduce re-admission rates for patients who were in acute respiratory failure?
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013
Nocturnal hypoventilation is associated with poor sleep quality and increased pulse rate variability in children
Source: Annual Congress 2009 - Sleep apnoea across the ages
Year: 2009
Stroke alert: sleep disordered breathing predicts survival?
Source: Eur Respir J 2004; 24: 195-196
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept